Laurence Tisi, CEO of ERBA Molecular and Co-founder of Lumora which was acquired by ERBA Mannheim in September 2015 to form ERBA Molecular. Laurence has been leading operations since 2003 and CEO since 2007, directing the R&D pipeline and day to day running of the company. He has helped Lumora raise £4.8M in funding before leading hugely successful exit for the investors and shareholders. He is a former winner of the 'Marlene Deluca Prize' for the research he performed on bioluminescence whilst at Cambridge University. He is a named inventor on several patents including Lumora's core 'BART' technology
Hayden Jeffreys ERBA Molecular Commercial Director (CCO). Hayden joined Lumora in 2013 as Commercial Director with a remit to further commercialise Lumora’s technologies including BART (Bioluminescent Assay in Real Time) as well as prepare the company for exit which was successfully achieved in September 2015. Hayden brings a wealth of experience from the molecular diagnostics industry which will be crucial to fulfilling ERBA Molecular duel strategy of licensing its technology to major commercial partners and . Before joining Lumora, Hayden was Divisional Director–Diagnostic Products at Lab21, and previously worked at Invitron, Gen-Probe and Molecular Light Technology.